Use of immune cell function assay in immune surveillance of lung transplant recipients: Correlations with clinical outcome and other immune assays

F. Bini, A. Grasso, S. Miserere, R. Di Domenica, M. Morosini, T. Oggionni, M. Cova, L. Maurizio, F. Meloni (Pavia, Italy)

Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Session: Optimising outcomes after lung transplantation
Session type: Thematic Poster Session
Number: 2441
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Bini, A. Grasso, S. Miserere, R. Di Domenica, M. Morosini, T. Oggionni, M. Cova, L. Maurizio, F. Meloni (Pavia, Italy). Use of immune cell function assay in immune surveillance of lung transplant recipients: Correlations with clinical outcome and other immune assays. Eur Respir J 2012; 40: Suppl. 56, 2441

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006

Development of a short-term whole blood intracellular staining assay to characterize the immune profile of pediatric patients
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017


The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Determinants of lung cancer evolution: immune escape and inflammation
Source: International Congress 2018 – Scientific Year in Review
Year: 2018


How to use new immunosuppressive drugs in lung transplantation
Source: Annual Congress 2006 - MP5 – How to use new immunosuppressive drugs in lung transplantation
Year: 2006

Cytotoxic T cell antigen 4 and the status of T cell activation in lung cancer: local vs. systemic immune response.
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017



Intracellular cytokines in blood T cells and monocytes in lung transplant patients - potential utility in monitoring immunosuppression protocols
Source: Eur Respir J 2004; 24: Suppl. 48, 452s
Year: 2004

Identification and characterisation of isolated human lung dendritic cells (DCs)
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006


Evaluation of specific immune complexes in patients with pulmonary sarcoidosis.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018


Evaluation of serial interferon-gamma release assay testing in lung cancer patients treated with immune checkpoint inhibitors
Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis
Year: 2021


Cytomegalovirus-specific cell-mediated immunity after prophylaxis predicts late-onset infection in lung transplantation
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020


Immunosuppressive properties of bronchial epithelial cells are altered in lung transplant recipients: “ex-vivo” model of T cell-allogeneic response
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013


How to evaluate the immune status of lung cancer patients before immunotherapy
Source: Breathe, 13 (4) 291; 10.1183/20734735.001917
Year: 2017



The lung in humoral immune deficiency: variety of manifestations
Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans
Year: 2013


Airway cellular response to two different immunosuppressive regimens in lung transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 466s
Year: 2004

How do antigen presenting cells see pathogens and cells?
Source: Annual Congress 2006 - Targeting innate immunity in respiratory diseases
Year: 2006


Transcriptomic analyses reveal anti-viral responses of epithelial cells and multiple immune cell types in HRV infected human lung tissue
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017

Monitoring T-cell immunity towards M. tuberculosis: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Breathprints of model murine bacterial lung infections are linked with immune response
Source: Eur Respir J 2015; 45: 181-190
Year: 2015